President and CEO of Phytomedical Technologies aciphex generic.

Phytomedical the in vivo toxicity and efficacy tests on Human Colon Cancer deliver promising resultsPhytomedical Technologies , announced today the results of its anti-cancer compound in vivo toxicity and efficacy successfully tests on HCT116 human colon cancer cells were aciphex generic . I am with the results of our human colon cancer toxicity and efficacy tests that allows us to climb further our development ladder is ‘m encouraged, said Mr. Greg Wujek, President and CEO of Phytomedical Technologies, We have made some important progress forward in the past year and on us in the next phase of our development path. .

About Phytomedical Technologies – Phytomedical Technologies, focuses together with its wholly owned subsidiaries, is a pharmaceutical company engaged in research, development and marketing of pharmaceutical products.

By Jill Stein Jill stone be a Paris based freelance medical writer.